Search
for
Sort by
Research 31–60 of 1000+
- The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men’s Health
- Novel inhibitors of 5α-reductase
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Dual inhibitors of urease and carbonic anhydrase-II from <i>Iris</i> species
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
- Dutasteride
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- The potential of androgenic alopecia management from plant derivatives
- Hair: What is New in Diagnosis and Management?
- Safety concerns when using novel medications to treat alopecia
- Adverse effects of common medications on male fertility
- Idiopathic Hirsutism*
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration
- Hormone therapy in acne
- Steroid Hormones
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor